These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 2478846)

  • 1. FK 506 for liver, kidney, and pancreas transplantation.
    Starzl TE; Todo S; Fung J; Demetris AJ; Venkataramman R; Jain A
    Lancet; 1989 Oct; 2(8670):1000-4. PubMed ID: 2478846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-tacrolimus combination immunosuppression.
    McAlister VC; Gao Z; Peltekian K; Domingues J; Mahalati K; MacDonald AS
    Lancet; 2000 Jan; 355(9201):376-7. PubMed ID: 10665560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
    Stratta RJ; Alloway RR; Hodge E; Lo A;
    Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver, kidney, and thoracic organ transplantation under FK 506.
    Todo S; Fung JJ; Starzl TE; Tzakis A; Demetris AJ; Kormos R; Jain A; Alessiani M; Takaya S; Shapiro R
    Ann Surg; 1990 Sep; 212(3):295-305; discussion 306-7. PubMed ID: 1697743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial.
    Bösmüller C; Ollinger R; Sieb M; Weissenbacher A; Schneeberger S; Pratschke J; Margreiter R
    Ann Transplant; 2012 Dec; 17(4):45-51. PubMed ID: 23274323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation.
    MacDonald AS
    Transplant Proc; 2003 May; 35(3 Suppl):201S-208S. PubMed ID: 12742497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction.
    Jain A; Sharma R; Ryan C; Tsoulfas G; Orloff M; Abt P; Kashyap R; Batzold P; Sauberman L; Safadjou S; Graham M; Bozorgzadeh A
    Liver Transpl; 2008 Feb; 14(2):202-9. PubMed ID: 18236395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
    Becker G; Witzke O; Friedrich J; Wagner K; Heemann U; Philipp T
    Transplant Proc; 1996 Dec; 28(6):3169-70. PubMed ID: 8962228
    [No Abstract]   [Full Text] [Related]  

  • 12. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants.
    Ciancio G; Miller J; Burke GW
    Clin Transplant; 2001 Apr; 15(2):142-5. PubMed ID: 11264642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of FK 506 in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Troppmann C; Gruessner AC
    Transpl Int; 1996; 9 Suppl 1():S251-7. PubMed ID: 8959841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.
    Bartlett ST; Schweitzer EJ; Johnson LB; Kuo PC; Papadimitriou JC; Drachenberg CB; Klassen DK; Hoehn-Saric EW; Weir MR; Imbembo AL
    Ann Surg; 1996 Oct; 224(4):440-9; discussion 449-52. PubMed ID: 8857849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basiliximab in the therapy of acute rejection after organ transplantation.
    Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH
    Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation.
    Winkler M; Pichlmayr R; Neuhaus P; McMaster P; Calne R; Otto G; Williams R; Bismuth H; Groth C
    Transpl Int; 1994; 7 Suppl 1():S58-63. PubMed ID: 11271312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.
    Jordan ML; Shapiro R; Vivas CA; Scantlebury VP; Darras FS; Carrieri G; McCauley J; Demetris AJ; Randhawa P; Jensen C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):638-40. PubMed ID: 7679827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.